JPMorgan Chase (NYSE: JPM) kicked off the first quarter earnings season today. The banking giant reported net income of $2.86Bil or $0.78 per share. Consumer & Community Banking (CCB) net income was down 95% to $191 million. Due to COVID-19 impact and continued pressure on oil prices, JPM’s provision for credit losses increased $6.8 billion to $8.3 billion. JPM shares gained over 3% immediately following the announcement.
Jamie Dimon, Chairman and CEO commented on the Q1 2020 results:
My heart goes out to the communities and individuals, including healthcare workers and first responders, most deeply hit by the COVID-19 crisis. Throughout our history, JPMorgan Chase has built its reputation on being there for clients, customers and communities in the most critical times. This unprecedented environment is no different. We will do everything in our power to help the world recover from this global crisis. The company entered this crisis in a position of strength, and we remain well capitalized and highly liquid – with a CET1 ratio of 11.5% and total liquidity resources of over $1 trillion.
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key